1. Zhe Yang*, Di Gao, Jing Zhao, Gaojie Yang, Ming Guo, Ying Wang, Xuechun Ren, Jong Seung Kim, Lin Jin *, Zhongmin Tian *, Xingcai Zhang *. Thermal-immuno-nanomedicine in cancer (2023), Nature Reviews Clinical Oncology, 20:116–134 （Cover, ESI高被引） IF：94.6
2. Xuechun Ren, Di Gao, Rong Yun, Xinyang Liu, Chenna Di, Zeyu Hu, Xinyuan Zhang, Zhongmin Tian and Zhe Yang* (Correspondence author). A urea-activated nanocarrier for site-specific SGLT2 inhibition and metabolic rescue against cardiovascular-kidney-metabolic syndrome, Nature Communications, 2026, 17(1): 6426 IF：18.1
3.Ren Xuechun, Gao Di, Liu Xinyang, Yun Rong, Wang Ying, Jia Liangliang, Ren Liujiao, Zhang Xinyuan, Xing Lijuan, Li Ke, Li Chengwei, Tian Zhongmin, Yang Zhe* (Correspondence author). UCST Polymeric H2S-Donor Fabricated Nanomedicine Managing Atherosclerosis by Gas-Photothermal Therapy Involving a "Turning Waste into Treasure" Strategy, Advanced Functional Materials, 2025, 35: 2419295. ESI 高被引IF：19.9
4.Di Gao, Xinyu He, Liangliang Jia, Xinyuan Zhang, Liujiao Ren, Xuechun Ren, Xinyang Liu, Rong Yun, Zeyu Hu, Zhongmin Tian* and Zhe Yang* (Correspondence author). Carrier-Free Nanoprodrug Mediating Laser Activable Chemotherapeutic Immunomodulation against Cancer, ACS Nano, 2025, 19: 31582-31597
5. Zhe Yang*, Liujiao Ren, Tian He, Pengfei Yang, Xinyang Liu, Chenna Di, Ronghua Wang, Di Gao, Lin Jin, Chengwei Li, Zhongmin Tian. On-demand hydrogen sulfide-releasing hydrogel reprogramming the diabetic wound microenvironment to accelerate healing, Biomaterials, 2026, 331:124129. IF：13.6
6. Zhe Yang*, Ying Zhou, Xiaozhen Liu, Liujiao Ren, Xinyang Liu, Rong Yun, Liangliang Jia, Xuechun Ren, Ying Wang, Yan Sun, Jia Li, Di Gao*, Zhongmin Tian*. Mitochondrial-uncoupling nanomedicine for self-heating and immunometabolism regulation in cancer cells (2025)，Biomaterials，314: 122883.
7. Ying Wang#, Di Gao#, Lin Jin#, Xuechun Ren, Yanan Ouyang, Ying Zhou, Xinyu He, Liangliang Jia, Zhongmin Tian*, Dingcai Wu*, Zhe Yang* (Correspondence author). NADPH Selective Depletion Nanomedicine‐Mediated Radio‐Immunometabolism Regulation for Strengthening Anti‐PDL1 Therapy against TNBC (2023). Advanced Science, 10 (3):2203788.
8. Gao Di, Chen Ting, Chen Shuojia, Ren Xuechun, Han Yulong, Li Yiwei, Wang Ying, Guo Xiaoqing, Wang Hao, Chen Xing, Guo Ming, Zhang Yu Shrike, Hong Guosong, Zhang Xingcai*, Tian Zhongmin*, Yang Zhe* (Correspondence author). Targeting Hypoxic Tumors with Hybrid Nanobullets for Oxygen-Independent Synergistic Photothermal and Thermodynamic Therapy (2021). Nano-Micro Letters, 12, 99. （Cover, 2022年曾入选ESI高被引）
9. Wang Y., Gao D., Liu Y., Guo X., Chen S., Zeng L., Ma J., Zhang X., Tian Z.*, Yang Z.* (Correspondence author). Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine (2021). Bioactive Materials, 6, 1513-1527. （2022年曾入选ESI高被引）
10. Yang Z., Gao D., Guo X., Jin L., Zheng J., Wang Y., Chen S., Zheng X., Zeng L., Guo M., Zhang X.*, Tian Z.* Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets (2020). ACS Nano, 14, 17442–17457. （曾入ESI热点论文及ESI高被引）